(19)
(11) EP 1 364 017 A2

(12)

(88) Date of publication A3:
10.07.2003

(43) Date of publication:
26.11.2003 Bulletin 2003/48

(21) Application number: 01980246.1

(22) Date of filing: 16.08.2001
(51) International Patent Classification (IPC)7C12N 15/12, C07K 14/705, C12N 15/11, C07K 16/28, G01N 33/50, A61K 39/395, A61K 38/17, A61K 31/7105
(86) International application number:
PCT/EP0109/466
(87) International publication number:
WO 0201/3845 (21.02.2002 Gazette 2002/08)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 18.08.2000 US 641653

(71) Applicants:
  • Novartis AG
    4002 Basel (CH)

    BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR 
  • Novartis Pharma GmbH
    1230 Wien (AT)

    AT 

(72) Inventors:
  • JARAI, Gabor,Novartis Horsham Research Centre
    Horsham,West Sussex RH12 5AB (GB)
  • YOUSEFI, Shida
    CH-3013 Bern (CH)

(74) Representative: Gros, Florent 
Novartis AG
4002 Basel
4002 Basel (CH)

   


(54) INFLAMMATION RELATED G-PROTEIN COUPLED RECEPTOR